Piper AD Affects 34,000 Aircraft

---------- Forwarded message ----------
From: FAASafety.gov <info_210410063@faasafety.gov>
Date: Wed, Feb 6, 2013 at 3:48 PM
Subject: "FAAST Blast" - FAASafety.gov

	FAA Safety Team | Safer Skies Through Education
FAAST Blast Notice Number: NOTC4567 FAAST Blast — Week of Feb 04 – Feb 10, 2013 Biweekly FAA Safety Briefing News Update Piper AD Affects 34,000 Aircraft             A new Airworthiness Directive (AD) was issued by the FAA to correct an unsafe condition on select models of Piper PA-28, PA-32, PA-34, and PA-44 aircraft. The AD, prompted by reports of control cable assembly failures that could result in loss of pitch control, requires inspections of the stabilator control system and replacement of parts as necessary. The AD goes into effect on March 11, 2013, and affects more than 34,000 aircraft of U.S. registry. For more details on the inspection procedures required with this AD, go to http://go.usa.gov/4yMz, or click the AD link from http://www.faa.gov.    FAA Issues SAIB for Piper Super Cub             On February 6, 2013, the FAA issued a Special Airworthiness Information Bulletin (SAIB) alerting owners and operators of Piper PA-18 (L-21) airplanes of cracking discovered in the weld joint of the aft fuselage tail post. If undetected, the cracking could become significant and result in a potential safety of flight hazard such as loss of control of the lower rudder hinge or tail wheel. The FAA recommends the affected Piper airplane models that have accumulated 1,000 hours total time in service (TIS) be inspected using a fluorescent penetrant and/or x-ray within the next 100 hours TIS in the fuselage tail post area, and then be repeated every 1,000 hours TIS. These inspections are particularly important if the aircraft is subject to operation in severe turbulence, towing, or on rough terrain. The SAIB also provides guidance on recommended inspections for various Piper airplane models with similar tail post configurations. For more information as well as a detailed x-ray view of a damaged area, go to http://go.usa.gov/4VjF.   From FDA to FAA             The need for careful evaluation of a drug's effects is the reason for the FAA's general policy of waiting a year after a drug receives FDA approval before it will be considered for use by airmen. A drug that successfully and effectively treats a particular condition on the ground may not be safe or suitable for use in the flying environment. Learn more about how the FAA evaluates drugs for aeromedical use in the Jan/Feb 2013 issue of FAA Safety Briefing at http://1.usa.gov/FAA_ASB.   Produced by the FAA Safety Briefing editors, http://www.faa.gov/news/safety_briefing/ Address questions or comments to: SafetyBriefing@faa.gov. Follow us on Twitter @FAASafetyBrief or http://www.twitter.com/SafetyBrief This notice is being sent to you because you selected "General Information" in your preferences on FAASafety.gov. If you wish to adjust your selections, log into https://www.faasafety.gov/Users/pub/preferences.aspx where you can update your preferences.
Invite a fellow pilot to the next WINGS Safety Seminar in your area
FAASafety.gov | Email Preferences | Opt Out
Do not reply to this email as it is an unmonitored mailbox. Contact us for comments or questions.